Filing Flows › Comparisons › PAYS vs OPRX
Paysign vs OptimizeRx: PAYS and OPRX compared
Paysign is the larger company: $28.3M of revenue in its latest quarter (Q2 2026) against $20.5M for OptimizeRx (Q2 2026). Paysign is growing faster (+48% against -30% a year earlier). Paysign is more profitable, with an operating margin of 24.8% against -0.4%.
Where the money goes: PAYS and OPRX
Paysign (PAYS) · Q2 2026
Paysign, Q2 2026: revenue $28.3M (+48% year over year), operating margin 24.8%, net earnings $6.8M, operating cash flow $1.3M. The chart follows the revenue to costs, profit and cash.
OptimizeRx (OPRX) · Q2 2026
OptimizeRx, Q2 2026: revenue $20.5M (-30% year over year), operating margin -0.4%, net loss $703K, operating cash flow $8.6M. The chart follows the revenue to costs, profit and cash.
| Paysign (PAYS) | OptimizeRx (OPRX) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $28.3M | $20.5M |
| Revenue growth, Y/Y | +48% | -30% |
| Gross margin | 63.3% | — |
| Operating margin | 24.8% | -0.4% |
| Net earnings | $6.8M | −$703K |
| Net margin | 23.9% | -3.4% |
| Operating cash flow | $1.3M | $8.6M |
| Free cash flow | $1.2M | $8.6M |
Where the revenue comes from
Paysign
- Pharma Industry: $14.6M (52%)
- Plasma Industry: $13.0M (46%)
- Other Revenue: $562K (2%)
- Breakage Revenue: $76K (0%)
Questions
Which is bigger, Paysign or OptimizeRx?
Paysign is the larger company: $28.3M of revenue in its latest quarter (Q2 2026) against $20.5M for OptimizeRx (Q2 2026).
Is Paysign or OptimizeRx growing faster?
Paysign is growing faster (+48% against -30% a year earlier).
Which is more profitable, Paysign or OptimizeRx?
Paysign is more profitable, with an operating margin of 24.8% against -0.4%.
More: Paysign earnings · how Paysign makes money · OptimizeRx earnings · how OptimizeRx makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 6, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.